Inceptionr LLC cut its holdings in shares of IMAX Corporation (NYSE:IMAX – Free Report) by 71.6% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 5,425 shares of the company’s stock after selling 13,686 shares during the period. Inceptionr LLC’s holdings in IMAX were worth $206,000 as of its most recent SEC filing.
Several other institutional investors also recently bought and sold shares of IMAX. CIBC Private Wealth Group LLC purchased a new stake in IMAX during the third quarter worth $27,000. Quarry LP increased its holdings in shares of IMAX by 166.8% in the 4th quarter. Quarry LP now owns 875 shares of the company’s stock valued at $32,000 after acquiring an additional 547 shares during the period. Caitong International Asset Management Co. Ltd increased its holdings in shares of IMAX by 2,310.4% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,157 shares of the company’s stock valued at $38,000 after acquiring an additional 1,109 shares during the period. Torren Management LLC bought a new position in shares of IMAX in the 4th quarter worth $40,000. Finally, Aster Capital Management DIFC Ltd raised its position in shares of IMAX by 863.0% in the 4th quarter. Aster Capital Management DIFC Ltd now owns 1,666 shares of the company’s stock worth $62,000 after acquiring an additional 1,493 shares in the last quarter. 93.51% of the stock is owned by hedge funds and other institutional investors.
IMAX Trading Up 4.6%
Shares of IMAX stock opened at $47.18 on Wednesday. The business’s fifty day simple moving average is $40.49 and its 200-day simple moving average is $38.20. The company has a market cap of $2.59 billion, a PE ratio of 65.53, a PEG ratio of 1.65 and a beta of 0.37. IMAX Corporation has a 12-month low of $24.20 and a 12-month high of $47.31.
Wall Street Analyst Weigh In
IMAX has been the subject of a number of analyst reports. Wells Fargo & Company upped their price objective on IMAX from $41.00 to $45.00 and gave the stock an “equal weight” rating in a research note on Friday, July 24th. Seaport Research Partners reiterated a “buy” rating and issued a $50.00 target price on shares of IMAX in a research note on Wednesday, June 24th. Keefe, Bruyette & Woods reiterated a “market perform” rating and issued a $60.00 target price on shares of IMAX in a report on Friday, May 22nd. Barrington Research increased their price target on shares of IMAX from $46.00 to $50.00 and gave the company an “outperform” rating in a research report on Friday, July 24th. Finally, Wedbush raised their price target on shares of IMAX from $46.00 to $54.00 and gave the company an “outperform” rating in a report on Friday, July 24th. Ten analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $50.36.
Check Out Our Latest Analysis on IMAX
Trending Headlines about IMAX
Here are the key news stories impacting IMAX this week:
- Positive Sentiment: Record-setting IMAX demand: The Odyssey has generated approximately $140 million in global IMAX box office, helping demonstrate the revenue potential of high-profile films released in the format. The Odyssey reaches $140 million in global IMAX box office
- Positive Sentiment: Broad global rollout ahead: IMAX China is preparing to show the film on nearly 800 screens, with its chief executive citing the “Christopher Nolan effect.” The rollout could extend the film’s strong contribution to IMAX admissions and increase international visibility for the brand. IMAX China prepares full Odyssey rollout
- Positive Sentiment: Scarcity is amplifying consumer interest: Reports of sold-out or difficult-to-find 70mm IMAX tickets, audiences traveling long distances, and theaters drawing visitors from across Europe suggest unusually strong engagement. That buzz may support premium ticket pricing and encourage future filmmakers to use IMAX cameras. Why is it so hard to see The Odyssey in 70mm IMAX?
- Positive Sentiment: Potential long-term format benefit: Coverage examining whether directors beyond Nolan can shoot entirely with IMAX cameras highlights the company’s opportunity to expand premium-format adoption beyond a single blockbuster filmmaker. Can Anyone Other Than Christopher Nolan Shoot a Film Entirely on Imax?
- Neutral Sentiment: The publicity is concentrated around The Odyssey and its limited 70mm presentation. While this strengthens near-term sentiment, investors will need evidence that demand can persist through additional releases and justify IMAX’s elevated valuation.
IMAX Profile
IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.
Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.
Further Reading
- Five stocks we like better than IMAX
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Want to see what other hedge funds are holding IMAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IMAX Corporation (NYSE:IMAX – Free Report).
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.
